BioSpace News Archive

Samumed, LLC, announced today that it has closed its A-6 Round of equity issuance with $438 million, bringing its total equity raised to date to more than $650 million. The pre-money valuation for the round was $12 billion.

Integrated into the pharmacy management platform, Computer-Rx customers now have access to HIPAA-compliant, two-way texting with patients and digital faxing with prescribers

Bragar Eagel & Squire, P.C. announces that class action lawsuits have been commenced on behalf of stockholders of Mercury Systems, Inc., Rockwell Medical, Inc., and Impinj, Inc.

Cautions the Board Against any Further Board Appointments or Governance Changes During the Pendency of the Consent Solicitation

Prometic Life Sciences Inc. announced that it will report its financial results for the second quarter ended June 30, 2018 on Tuesday August 14, 2018 after market close.

Vital Therapies, Inc. announced results for the second quarter ended June 30, 2018.

Entered into agreement to acquire Agilis Biotherapeutics

Array BioPharma Inc. will report financial results for the fourth quarter and full year of fiscal 2018 and hold a conference call to discuss those results on Tuesday, August 14, 2018. Ron Squarer, Chief Executive Officer, will lead the call.

-Strong execution of Toca 5 Phase 3 clinical trial with upcoming milestones on track- -Projected year-end 2018 cash position increased to approximately $70 million- [07-August-2018] SAN DIEGO, Aug. 7, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and b

Q2 2018 Sales Revenue up 58.5% Over the Same Period in 2017